文献速递产科母胎医学

产前糖皮质激素对早产小于胎龄儿的影响:系统综述与荟萃分析

Antenatal corticosteroids in preterm small-for-gestational age infants: a systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol MFM · 2020-08-17

该系统综述与荟萃分析纳入16项观察性研究(8989例早产小于胎龄儿),其中13项研究(6387例)进入荟萃分析。结果显示,产前糖皮质激素暴露与新生儿死亡率显著降低相关(OR 0.63,95%CI 0.46-0.86),但对呼吸窘迫综合征、坏死性小肠结肠炎、脑室内出血/脑室周围白质软化、支气管肺发育不良/慢性肺疾病及新生儿败血症均无显著影响。结论支持对早产小于胎龄儿使用产前糖皮质激素以降低新生儿死亡率。

要点

  • 产前糖皮质激素可降低早产小于胎龄儿的新生儿死亡率(OR 0.63)。
  • 对呼吸窘迫综合征等主要新生儿疾病无显著影响。
  • 证据来自观察性研究,存在显著异质性,需谨慎解读。

核心结论

  • 产前糖皮质激素可降低早产小于胎龄儿的新生儿死亡率,对新生儿疾病无明显影响。

研究设计与样本

  • 系统综述与荟萃分析,检索1970至2019年多个数据库,最终纳入16项观察性队列和病例对照研究,共8989例早产小于胎龄儿;其中13项研究(6387例)进入荟萃分析。

主要发现

  • 新生儿死亡率:12项研究,产前糖皮质激素组12.8% vs 未暴露组15.1%,合并OR 0.63(95%CI 0.46-0.86),异质性I2=55.1%(P=.011)。
  • 呼吸窘迫综合征:12项研究,OR 0.89(95%CI 0.69-1.15),无显著差异。
  • 坏死性小肠结肠炎:7项研究,OR 0.93(95%CI 0.70-1.22),无显著差异。
  • 脑室内出血和/或脑室周围白质软化:10项研究,OR 0.82(95%CI 0.56-1.20),无显著差异。
  • 支气管肺发育不良或慢性肺疾病:8项研究,OR 1.11(95%CI 0.88-1.41);新生儿败血症:6项研究,OR 1.13(95%CI 0.86-1.49),均无显著差异。

临床怎么用

  • 对于有早产风险的小于胎龄儿孕妇,可考虑使用产前糖皮质激素以降低新生儿死亡率。
  • 应告知患者该治疗对新生儿主要疾病发生率无显著改善,且证据主要来自观察性研究。

局限性

  • 纳入研究均为观察性设计,可能存在残余混杂。
  • 新生儿死亡率分析存在显著异质性(I2=55.1%)。
  • 部分结局的合并分析纳入研究数量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to estimate the effect of antenatal corticosteroid administration on neonatal mortality and morbidity in preterm small-for-gestational age infants through a systematic review and meta-analysis. DATA SOURCES: A predefined, systematic search was conducted through Ovid MEDLINE, Embase, Scopus, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, World Health Organization International Clinical Trial Registry Platform, and ClinicalTrials.gov yielding 5324 articles from 1970 to 2019. STUDY ELIGIBILITY CRITERIA: Eligible studies compared neonatal morbidity and mortality among small-for-gestational age infants delivered preterm who received antenatal corticosteroids with those who did not. METHODS: The primary outcome was neonatal mortality. Secondary outcomes were respiratory distress syndrome, necrotizing enterocolitis, intraventricular hemorrhage and periventricular leukomalacia, bronchopulmonary dysplasia or chronic lung disease of prematurity, or neonatal sepsis. We assessed heterogeneity by means of Higgins I2 statistic and Cochran's Q test and calculated pooled odds ratios with 95% confidence intervals using random effects models. RESULTS: A total of 16 observational cohort and case-control studies published from 1995 to 2018 met the selection criteria for the systematic review and included 8989 preterm small-for-gestational age infants. Antenatal corticosteroid administration was explicitly reported among 8376 small-for-gestational age infants; 4631 (55.3%) received antenatal corticosteroids and 3741 (44.7%) did not. Of note, 13 studies including 6387 preterm small-for-gestational age infants were then included in the meta-analysis. Neonatal mortality was significantly lower among infants who received antenatal corticosteroids than those who did not (12 studies: 12.8% vs 15.1%; pooled odds ratio, 0.63; 95% confidence interval, 0.46-0.86), with significant heterogeneity between studies (I2=55.1%; P=.011). There was no significant difference in respiratory distress syndrome (12 studies: odds ratio, 0.89; 95% confidence interval, 0.69-1.15), necrotizing enterocolitis (7 studies: odds ratio, 0.93; 95% confidence interval, 0.70-1.22), intraventricular hemorrhage and periventricular leukomalacia (10 studies: odds ratio, 0.82; 95% confidence interval, 0.56-1.20), bronchopulmonary dysplasia or chronic lung disease of prematurity (8 studies: odds ratio, 1.11; 95% confidence interval, 0.88-1.41), or neonatal sepsis (6 studies: odds ratio, 1.13; 95% confidence interval, 0.86-1.49). CONCLUSION: These data indicate that antenatal corticosteroid administration reduces neonatal mortality in small-for-gestational age infants delivered preterm, with no apparent effect on neonatal morbidity. This supports the use of antenatal corticosteroids to reduce neonatal mortality in pregnancies with small-for-gestational age infants at risk of preterm birth.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Blankenship SA, Brown KE, Simon LE, et al. Antenatal corticosteroids in preterm small-for-gestational age infants: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020. PMID: 33345924. doi:10.1016/j.ajogmf.2020.100215

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。